Many are creating new drugs, not just generics, which the large pharmaceutical companies are often against.However, despite there being a market opportunity here for these smaller firms, they ???typically lack expertise in such areas as international regulatory environments, market assessments, positioning products, including pricing, accessing financing, and identifying international commercializ